|

Cessation of somatostatin analogues Clinical Trials

1 actively recruiting trial

Also known as: SSA cessation

Pipeline

Phase 2: 1

Top Sponsors

  • Australasian Gastro-Intestinal Trials Group1

Indications

  • Neuroendocrine Tumors1
  • Cancer1

Other1 trial

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.